V010-6193 Screening compound: 4-(3-chlorophenyl)-2-(4-fluorophenyl)-6-(morpholin-4-yl)-2H-pyrazolo[3,4-d]pyrimidin-3-amine

V010-6193 Screening compound: 4-(3-chlorophenyl)-2-(4-fluorophenyl)-6-(morpholin-4-yl)-2H-pyrazolo[3,4-d]pyrimidin-3-amine
V010-6193 Screening compound: 4-(3-chlorophenyl)-2-(4-fluorophenyl)-6-(morpholin-4-yl)-2H-pyrazolo[3,4-d]pyrimidin-3-amine alternative view

Chemical Structure Depiction of ChemDiv screening compound V010-6193
4-(3-chlorophenyl)-2-(4-fluorophenyl)-6-(morpholin-4-yl)-2H-pyrazolo[3,4-d]pyrimidin-3-amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V010-6193

Molecular Formula

C21H18ClFN6O (C21 H18 ClFN6 O)

Compound Name

4-(3-chlorophenyl)-2-(4-fluorophenyl)-6-(morpholin-4-yl)-2H-pyrazolo[3,4-d]pyrimidin-3-amine

IUPAC name

4-(3-chlorophenyl)-2-(4-fluorophenyl)-6-(morpholin-4-yl)-2H-pyrazolo[34-d]pyrimidin-3-amine

SMILES

Nc1c2c(-c3cccc(Cl)c3)nc(N3CCOCC3)nc2nn1-c(cc1)ccc1F

InChI

InChI=1S/C21H18ClFN6O/c22-14-3-1-2-13(12-14)18-17-19(24)29(16-6-4-15(23)5-7-16)27-20(17)26-21(25-18)28-8-10-30-11-9-28/h1-7,12H,8-11,24H2

InChI Key

XMCXWTAEGBIZFB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14249284

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

424.86

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.434

Distribution Coefficient, logD

4.433

Water Solubility, LogSw

-4.71

Polar Surface Area

63.730

Acid Dissociation Constant (pKa)

20.42

Base Dissociation Constant (pKb)

4.82

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

19.00

V010-6193 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V010-6193 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V010-6193?
Check Price and Availability of V010-6193, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V010-6193 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V010-6193
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V010-6193
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V010-6193 available by request